human rage quantikine elisa kit Search Results


human rage quantikine elisa kit  (R&D Systems)
95
R&D Systems human rage quantikine elisa kit
<t>ELISA</t> of AGEs and sRAGE in serum blood from controls (CNT) and fibrosing ILDs. a and b ELISA for total AGEs and sRAGE showed significant differences between control group with IPF and cHP (* p < 0.01), and differences between fNSIP patients with IPF (# p < 0.01) and cHP (§ p < 0.01) groups. However, there were no significant differences between IPF with cHP and control with fNSIP. c AGEs/sRAGE ratio estimated by ELISA was greater in IPF and cHP groups compared with control (* p < 0.01). The ratio also allowed to distinguish between IPF patients with cHP and fNSIP (# p < 0.05), and cHP with fNSIP group (§ p < 0.01), whereas this did not distinguish between control and fNSIP patients. Data were analyzed by one-way ANOVA following by the appropriate post-hoc analysis
Human Rage Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human rage quantikine elisa kit/product/R&D Systems
Average 95 stars, based on 1 article reviews
human rage quantikine elisa kit - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


ELISA of AGEs and sRAGE in serum blood from controls (CNT) and fibrosing ILDs. a and b ELISA for total AGEs and sRAGE showed significant differences between control group with IPF and cHP (* p < 0.01), and differences between fNSIP patients with IPF (# p < 0.01) and cHP (§ p < 0.01) groups. However, there were no significant differences between IPF with cHP and control with fNSIP. c AGEs/sRAGE ratio estimated by ELISA was greater in IPF and cHP groups compared with control (* p < 0.01). The ratio also allowed to distinguish between IPF patients with cHP and fNSIP (# p < 0.05), and cHP with fNSIP group (§ p < 0.01), whereas this did not distinguish between control and fNSIP patients. Data were analyzed by one-way ANOVA following by the appropriate post-hoc analysis

Journal: Respiratory Research

Article Title: Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis

doi: 10.1186/s12931-018-0924-7

Figure Lengend Snippet: ELISA of AGEs and sRAGE in serum blood from controls (CNT) and fibrosing ILDs. a and b ELISA for total AGEs and sRAGE showed significant differences between control group with IPF and cHP (* p < 0.01), and differences between fNSIP patients with IPF (# p < 0.01) and cHP (§ p < 0.01) groups. However, there were no significant differences between IPF with cHP and control with fNSIP. c AGEs/sRAGE ratio estimated by ELISA was greater in IPF and cHP groups compared with control (* p < 0.01). The ratio also allowed to distinguish between IPF patients with cHP and fNSIP (# p < 0.05), and cHP with fNSIP group (§ p < 0.01), whereas this did not distinguish between control and fNSIP patients. Data were analyzed by one-way ANOVA following by the appropriate post-hoc analysis

Article Snippet: AGE and sRAGE were measured by specific commercial ELISA kit; Human RAGE Quantikine ELISA Kit (DRG00; R&D Systems, USA) and Human AGEs ELISA Kit (CSB-E09412h; Cusabio Biotech Co., China), following the manufacturer’s recommendations.

Techniques: Enzyme-linked Immunosorbent Assay, Control

ELISA measurements and lung function from IPF patients at 3-year interval

Journal: Respiratory Research

Article Title: Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis

doi: 10.1186/s12931-018-0924-7

Figure Lengend Snippet: ELISA measurements and lung function from IPF patients at 3-year interval

Article Snippet: AGE and sRAGE were measured by specific commercial ELISA kit; Human RAGE Quantikine ELISA Kit (DRG00; R&D Systems, USA) and Human AGEs ELISA Kit (CSB-E09412h; Cusabio Biotech Co., China), following the manufacturer’s recommendations.

Techniques: Enzyme-linked Immunosorbent Assay

Correlation between changes in ELISA measurements and lung function

Journal: Respiratory Research

Article Title: Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis

doi: 10.1186/s12931-018-0924-7

Figure Lengend Snippet: Correlation between changes in ELISA measurements and lung function

Article Snippet: AGE and sRAGE were measured by specific commercial ELISA kit; Human RAGE Quantikine ELISA Kit (DRG00; R&D Systems, USA) and Human AGEs ELISA Kit (CSB-E09412h; Cusabio Biotech Co., China), following the manufacturer’s recommendations.

Techniques: Enzyme-linked Immunosorbent Assay

Correlation between changes in DLCO and differences in sRAGE-AGEs levels in IPF patients. a In IPF patients, a decline of DLCO was related with a decrease of sRAGE in serum ( r = 0.555, p < 0.01). b and c On the contrary, AGEs levels and the AGEs/sRAGE ratio were negatively correlated with the percentage of changes in DLCO in IPF patients ( r = − 0.747 and − 0704, respectively, p < 0.01), meaning poor lung function in patients with an increase of AGEs-sRAGE imbalance over time. The changes in serum sRAGE and AGEs and lung function from IPF patients was calculated, adjusting over time: Δ ELISA in a month = [ELISA final – ELISA initial]/month; change of % predicted PFT = [PFT final – PFTs initial]/month. Pearson’s correlation coefficients were performed to analyze the lineal relationship between the variables

Journal: Respiratory Research

Article Title: Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis

doi: 10.1186/s12931-018-0924-7

Figure Lengend Snippet: Correlation between changes in DLCO and differences in sRAGE-AGEs levels in IPF patients. a In IPF patients, a decline of DLCO was related with a decrease of sRAGE in serum ( r = 0.555, p < 0.01). b and c On the contrary, AGEs levels and the AGEs/sRAGE ratio were negatively correlated with the percentage of changes in DLCO in IPF patients ( r = − 0.747 and − 0704, respectively, p < 0.01), meaning poor lung function in patients with an increase of AGEs-sRAGE imbalance over time. The changes in serum sRAGE and AGEs and lung function from IPF patients was calculated, adjusting over time: Δ ELISA in a month = [ELISA final – ELISA initial]/month; change of % predicted PFT = [PFT final – PFTs initial]/month. Pearson’s correlation coefficients were performed to analyze the lineal relationship between the variables

Article Snippet: AGE and sRAGE were measured by specific commercial ELISA kit; Human RAGE Quantikine ELISA Kit (DRG00; R&D Systems, USA) and Human AGEs ELISA Kit (CSB-E09412h; Cusabio Biotech Co., China), following the manufacturer’s recommendations.

Techniques: Enzyme-linked Immunosorbent Assay